Can this struggling healthcare specialist turn things around?Medtronic (MDT -0.21%) is a leading global medical device company with a massive presence that spans more than 150 countries. Its products assist patients with over 70 different health conditions. Investing in the stock is a potentially great way to gain exposure to the healthcare industry as a whole.Over the past five years, however, its shares have been a lackluster investment, falling by 8%. What should you do with Medtronic stock: buy, sell, o ...

According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issuesDUBLIN, April 17, 2024 /PRNewswire/ -- Americans overwhelmingly say that when they think about longevity, it's more than just living longer—it's about living their healthiest, best lives. While most want to live to 90—well past the average U.S. life expectancy of 77.5 years—nearly two-thirds (66%) would choose a shorter, healthier lif ...

Moussa81 Buying quality companies at reasonable prices remains a winning investment strategy in my opinion despite all the noise around high-flying Al names on the market today. What's even better is if those stocks pay you a decent yield for holding onto them, which makes natural price volatility easier to bear. This brings me to Medtronic (NYSE:MDT), which I last covered in August with a 'Buy' rating, noting its undervaluation, strong balance sheet, and positioning for international growth. Since my l ...

Altayb/E+ via Getty ImagesIntroduction Allow me to start this article by showing you a chart I have used quite a few times in the past few months. As we can see below, the market has a quite lofty valuation. The S&P 500 traded at 21x earnings going into this month. That's 1.3x its long-term standard deviation. In fact, it's the third-most expensive market since the early 1990s. Only the Dotcom and post-pandemic periods were more expensive. JPMorganThis does not mean that stocks are due for a massive sel ...

Medtronic (MDT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this medical device company have returned -2.6% over the past month versus the Zacks S&P 500 composite's +1.6% change. The Zacks Medical - Products industry, to which Medtronic belongs, has lost 3% over this period. Now the key question is: Where could the stock be headed in the near term?While media relea ...

Medtronic plc (MDT) recently presented positive clinical trial safety and efficacy results for Sphere-360 -- an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy The catheter is intended for treatment of patients with paroxysmal atrial fibrillation (AFib).The European Heart Rhythm Association (EHRA) 2024 Annual Meeting featured a late-breaking clinical trial showcasing interim findings from the first-in-human Sphere-360 investigation.About Sphere-360 CatheterThe Sphere ...

FN Media Group News Commentary PALM BEACH, Fla., April 10, 2024 /PRNewswire/ -- With the increase in life expectancy, people need more medical help and care. AI-enabled technologies can help people to live healthier and longer lives. Artificial Intelligence (A.I.) has a great demand in the healthcare industry. Healthcare providers turn to tech companies for expertise in adopting AI, and naturally, demand for such expertise makes competition among the latter highly intensive.  A report from binariks.com pro ...

AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy DUBLIN, April 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care. GI Genius™ wa ...

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation SystemDUBLIN and BERLIN, April 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical trial safety and efficacy results for Sphere-360™, an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment of patients with paroxysmal atrial ...

New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien™ at one year DUBLIN and ATLANTA, April 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), were presented as a late breaking clinical trial at the American Coll ...